Immunogenicity, Safety, and Efficacy of Zarzio®/Filgrastim HEXAL® in Patients With Severe Chronic Neutropenia
Stopped Additional pharmacovigilance activity was considered as fulfilled by the EMA.
Conditions
- Severe Chronic Neutropenia
Interventions
Sponsor
Sandoz
Collaborators